CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition

Cell Death and Differentiation

Volumn 21, Issue 11, 2014, Pages 1746-1757

  Murakami, Y ^a   Tian, L ^a   Voss, O H ^a   Margulies, D H ^a   Krzewski, K ^a   Coligan, J E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; LMIR5 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLSERINE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, MOUSE;

ANIMAL; APOPTOSIS; HUMAN; METABOLISM; MOUSE; PHAGOCYTOSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; HUMANS; MICE; PHAGOCYTOSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLSERINES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84932168045     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.86     Document Type: Article

References (50)

1. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ 2008; 15: 243-250.
2. Flannagan RS, Jaumouille V, Grinstein S. The cell biology of phagocytosis. Annu Rev Pathol 2012; 7: 61-98.
3. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784-788.
4. Stuart LM, Ezekowitz RA. Phagocytosis and comparative innate immunity: Learning on the fly. Nat Rev Immunol 2008; 8: 131-141.
5. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: Implications in health and disease. J Cell Biol 2010; 189: 1059-1070.
6. Ferguson TA, Choi J, Green DR. Armed response: how dying cells influence T-cell functions. Immunol Rev 2011; 241: 77-88.
7. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14: 277-287.
8. Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 2010; 584: 4491-4499.
9. Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH et al. Rapid cell corpse clearance by Stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 2008; 15: 192-201.
10. Park SY, Jung MY, Lee SJ, Kang KB, Gratchev A, Riabov V et al. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci 2009; 122: 3365-3373.
11. Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE et al. Tim1 and Tim4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27: 927-940.
12. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007; 450: 435-439.
13. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z et al. Bai1 is an engulfment receptor for apoptotic cells upstream of the Elmo/Dock180/Rac module. Nature 2007; 450: 430-434.
14. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417: 182-187.
15. Lemke G, Rothlin CV. Immunobiology of the Tam receptors. Nat Rev Immunol 2008; 8: 327-336.
16. Nakahashi-Oda C, Tahara-Hanaoka S, Honda S, Shibuya K, Shibuya A. Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem Biophys Res Commun 2012; 417: 646-650.
17. Simhadri VR, Andersen JF, Calvo E, Choi SC, Coligan JE, Borrego F. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 2012; 119: 2799-2809.
18. Choi SC, Simhadri VR, Tian L, Gil-Krzewska A, Krzewski K, Borrego F et al. Cutting edge: Mouse CD300f (CMRF-35-like molecule-1) recognizes outer membraneexposed phosphatidylserine and can promote phagocytosis. J Immunol 2011; 187: 3483-3487.
19. Tian L, Choi SC, Murakami Y, Allen J, Morse Iii HC, Qi CF et al. P85a recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression. Nat Commun 2014; 5: 3146.
20. Borrego F. The CD300 molecules: An emerging family of regulators of the immune system. Blood 2013; 121: 1951-1960.
21. Yamanishi Y, Kitaura J, Izawa K, Matsuoka T, Oki T, Lu Y et al. Analysis of mouse LMIR5/CLM-7 as an activating receptor: Differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 2008; 111: 688-698.
22. Yamanishi Y, Takahashi M, Izawa K, Isobe M, Ito S, Tsuchiya A et al. A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J Immunol 2012; 189: 1773-1779.
23. Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, Nakamura M et al. Tim1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med 2010; 207: 1501-1511.
24. Cannon JP, O'Driscoll M, Litman GW. Specific lipid recognition is a general feature of CD300 and trem molecules. Immunogenetics 2012; 64: 39-47.
25. Izawa K, Yamanishi Y, Maehara A, Takahashi M, Isobe M, Ito S et al. The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 2012; 37: 827-839.
26. Nakahashi-Oda C, Tahara-Hanaoka S, Shoji M, Okoshi Y, Nakano-Yokomizo T, Ohkohchi N et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J Exp Med 2012; 209: 1493-1503.
27. Toda S, Hanayama R, Nagata S. Two-step engulfment of apoptotic cells. Mol Cell Biol 2012; 32: 118-125.
28. Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol 2007; 7: 155-161.
29. Iwaszko M, Bogunia-Kubik K. Clinical significance of the HLA-E and CD94/NKg2 interaction. Arch Immunol Ther Exp (Warsz) 2011; 59: 353-367.
30. Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated t lymphocytes. J Exp Med 1992; 176: 1595-1604.
31. Parham P. Killer cell immunoglobulin-like receptor diversity: Balancing signals in the natural killer cell response. Immunol Lett 2004; 92: 11-13.
32. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005; 115: 433-440.
33. Kubagawa H, Chen CC, Ho LH, Shimada TS, Gartland L, Mashburn C et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-a and PIR-b. J Exp Med 1999; 189: 309-318.
34. Xi H, Katschke Jr KJ, Helmy KY, Wark PA, Kljavin N, Clark H et al. Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1. J Exp Med 2010; 207: 7-16.
35. Wever KE, Wagener FA, Frielink C, Boerman OC, Scheffer GJ, Allison A et al. Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue. PLoS One 2011; 6: e24276.
36. Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK et al. Diannexin, a novel Annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 2007; 133: 632-646.
37. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011; 6: 19-48.
38. Rothlin CV, Lemke G. Tam receptor signaling and autoimmune disease. Curr Opin Immunol 2010; 22: 740-746.
39. Albacker LA, Yu S, Bedoret D, Lee WL, Umetsu SE, Monahan S et al. Tim4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells. Mucosal Immunol 2013; 6: 580-590.
40. Flannagan RS, Canton J, Furuya W, Glogauer M, Grinstein S. The phosphatidylserine receptor Tim4 utilizes integrins as coreceptors to effect phagocytosis. Mol Biol Cell 2014; 25: 1511-1522.
41. Baghdadi M, Yoneda A, Yamashina T, Nagao H, Komohara Y, Nagai S et al. Tim4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance. Immunity 2013; 39: 1070-1081.
42. Hochreiter-Hufford AE, Lee CS, Kinchen JM, Sokolowski JD, Arandjelovic S, Call JA et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature 2013; 497: 263-267.
43. Elliott MR, Zheng S, Park D, Woodson RI, Reardon MA, Juncadella IJ et al. Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo. Nature 2010; 467: 333-337.
44. Park SY, Kang KB, Thapa N, Kim SY, Lee SJ, Kim IS. Requirement of adaptor protein GULP during Stabilin-2-mediated cell corpse engulfment. J Biol Chem 2008; 283: 10593-10600.
45. Nishi C, Toda S, Segawa K, Nagata S. Tim4-and MerTK-mediated engulfment of apoptotic cells by mouse resident peritoneal macrophages. Mol Cell Biol 2014; 34: 1512-1520.
46. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
47. Jehle AW, Gardai SJ, Li S, Linsel-Nitschke P, Morimoto K, Janssen WJ et al. ATP-binding cassette transporter a7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages. J Cell Biol 2006; 174: 547-556.
48. Osada Y, Shiratsuchi A, Nakanishi Y. Involvement of mitogen-activated protein kinases in class b Scavenger Receptor type I-induced phagocytosis of apoptotic cells. Exp Cell Res 2006; 312: 1820-1830.
49. Hupfeld S, Holsaeter AM, Skar M, Frantzen CB, Brandl M. Liposome size analysis by dynamic/static light scattering upon size exclusion-/field flow-fractionation. J Nanosci Nanotechnol 2006; 6: 3025-3031.
50. Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F et al. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol 2013; 190: 987-996.